Interference 103,579 other factors are involved. Having considered the evidence in the art up to its submission for publication, Kuipers’ 1995 publication generally concludes that “antisense RNA-mediated inhibition of the expression of the GBSS gene offers good prospects for the production of amylose-free tuber starch in potato cultivars” (VDX 4, p. 754 [sic 753], col. 1, last para., last sentence; emphasis added). Here, as in In re Dow Chem. Co., 837 F.2d at 473, 5 USPQ2d at 1532: There must be a reason or suggestion in the art for selecting the procedure [employing the DNA sequence in the antisense direction that the other party] used, other than the knowledge learned from the . . . [other party’s] disclosure. . . . . Of the many scientific publications cited . . . none suggests that any [other] process could be used successfully . . . to produce this product having the desired properties. Absent any reason or suggestion in the prior art to use the constructs comprising the DNA sequences of distinct chemical structure in the antisense direction which the other party inserted into the genome of a potato plant to inhibit PGBSS gene expression in the potato plant with reasonable expectation of success, the claimed inventions of each party to this interference remain prima facie separately patentable over the claimed inventions of the other party to this interference based on the patentably distinct chemical structures of the DNA -120-Page: Previous 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 NextLast modified: November 3, 2007